Consultant for Translational R&D
- Efficacious drugs in therapeutic areas with high unmet medical need
- Safety margin resulting in convincing therapeutic window and allowing individual dosing
- Precision drugs targeting the right patient population and reducing failure rate
- Successful translational research strategy based on human drug target validation
- Decisive data enabling go/no-go decisions
- Risk mitigation strategy
- Identifies key experiments mitigating the risk of clinical failure
- Integrates clinical and non-clinical requirements to speed up drug development
- Anticipates and considers regulatory needs for successful milestone coverage
- Efficacious drugs in therapeutic areas with high unmet medical need
- Safety margin resulting in convincing therapeutic window and allowing individual dosing
- Precision drugs targeting the right patient population and reducing failure rate
- Successful translational research strategy based on human drug target validation
- Decisive data enabling go/no-go decisions
- Risk mitigation strategy
- Identifies key experiments mitigating the risk of clinical failure
- Integrates clinical and non-clinical requirements to speed up drug development
- Anticipates and considers regulatory needs for successful milestone coverage
Blog
EFIC 2025 Pain in Europe XIV, Lyon
From April 24 to 26, pain specialists and researchers convene in Lyon at the EFIC 2025. I continue with my personal selection of notable poster presentations regarding translational pain research.
10th BioRiver Boost! 2023
The 10th edition of BioRiver’s competition boosting young Startups into networking of the NRW biotech scene was held at the LifeHub Monheim on Sep 22, 2023.
Teaching is Fun
Students fascinated by Drug Development will pave the way for innovative treatments.
